Target-mediated drug disposition with drug–drug interaction, Part I: single drug case in alternative formulations

Target-mediated drug disposition (TMDD) describes drug binding with high affinity to a target such as a receptor. In application TMDD models are often over-parameterized and quasi-equilibrium (QE) or quasi-steady state (QSS) approximations are essential to reduce the number of parameters. However, implementation of such approximations becomes difficult for TMDD models with drug–drug interaction (DDI) mechanisms. Hence, alternative but equivalent formulations are necessary for QE or QSS approximations. To introduce and develop such formulations, the single drug case is reanalyzed. This work opens the route for straightforward implementation of QE or QSS approximations of DDI TMDD models. The manuscript is the first part to introduce DDI TMDD models with QE or QSS approximations.

[1]  D. Goussis,et al.  Glycolysis in Saccharomyces cerevisiae: algorithmic exploration of robustness and origin of oscillations. , 2013, Mathematical biosciences.

[2]  Theoretical Considerations of Target-Mediated Drug Disposition Models: Simplifications and Approximations , 2012, Pharmaceutical Research.

[3]  J. Gabrielsson,et al.  Dynamics of target-mediated drug disposition: how a drug reaches its target , 2013, Computational Geosciences.

[4]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[5]  Johan Gabrielsson,et al.  Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification , 2012, Journal of Pharmacokinetics and Pharmacodynamics.

[6]  W. Jusko,et al.  Minimal physiologically-based pharmacokinetic (mPBPK) model for a monoclonal antibody against interleukin-6 in mice with collagen-induced arthritis , 2016, Journal of Pharmacokinetics and Pharmacodynamics.

[7]  D. Mager,et al.  Numerical validation and properties of a rapid binding approximation of a target-mediated drug disposition pharmacokinetic model , 2009, Journal of Pharmacokinetics and Pharmacodynamics.

[8]  D. Mager,et al.  Quasi-Equilibrium Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition , 2005, Pharmaceutical Research.

[9]  W. Huisinga,et al.  Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosis , 2009, Journal of Pharmacokinetics and Pharmacodynamics.

[10]  J. Schropp,et al.  Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases , 2017, Journal of Pharmacokinetics and Pharmacodynamics.

[11]  PH van der Graaf,et al.  A Tutorial on Target-Mediated Drug Disposition (TMDD) Models , 2015, CPT: pharmacometrics & systems pharmacology.

[12]  Leonid Gibiansky,et al.  Approximations of the target-mediated drug disposition model and identifiability of model parameters , 2008, Journal of Pharmacokinetics and Pharmacodynamics.

[13]  D. Goussis,et al.  Asymptotic Analysis of a Target-Mediated Drug Disposition Model: Algorithmic and Traditional Approaches , 2016, Bulletin of mathematical biology.

[14]  W. Krzyzanski,et al.  Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor , 2012, Journal of Pharmacokinetics and Pharmacodynamics.

[15]  L. Gibiansky,et al.  Target-mediated drug disposition model for drugs that bind to more than one target , 2010, Journal of Pharmacokinetics and Pharmacodynamics.

[16]  G. An,et al.  Small‐Molecule Compounds Exhibiting Target‐Mediated Drug Disposition (TMDD): A Minireview , 2017, Journal of clinical pharmacology.

[17]  Mauro Valorani,et al.  An efficient iterative algorithm for the approximation of the fast and slow dynamics of stiff systems , 2006, J. Comput. Phys..

[18]  E. Hairer,et al.  Solving Ordinary Differential Equations II: Stiff and Differential-Algebraic Problems , 2010 .

[19]  L. Gibiansky,et al.  Target-mediated drug disposition model and its approximations for antibody–drug conjugates , 2013, Journal of Pharmacokinetics and Pharmacodynamics.

[20]  William J. Jusko,et al.  Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies , 2014, Journal of Pharmacokinetics and Pharmacodynamics.

[21]  Neil Fenichel Geometric singular perturbation theory for ordinary differential equations , 1979 .

[22]  A. B. Vasil’eva ASYMPTOTIC BEHAVIOUR OF SOLUTIONS TO CERTAIN PROBLEMS INVOLVING NON-LINEAR DIFFERENTIAL EQUATIONS CONTAINING A?SMALL PARAMETER MULTIPLYING THE HIGHEST DERIVATIVES , 1963 .

[23]  G Levy,et al.  Pharmacologic target‐mediated drug disposition , 1994, Clinical pharmacology and therapeutics.

[24]  M. A. Akanbi,et al.  Numerical solution of initial value problems in differential - algebraic equations , 2005 .

[25]  Ss Beal,et al.  NONMEM User’s Guides. (1989–2009) , 2009 .

[26]  Donald E. Mager,et al.  General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[27]  Ernst Hairer,et al.  Examples of Stiff Equations , 1996 .